SEC Form 4 research

LEXICON PHARMACEUTICALS, INC./DE insider transactions

Issuer	LEXICON PHARMACEUTICALS, INC./DE
Tickers	LEXG, LXRX
Reporting owners	65
Officers and directors	34
Last public filing	2026-10-23

Recent insider disclosures

No matching recent records; this is not a statement about historical activity.

Officers and directors in the directory

DEBBANE RAYMOND — 94 qualifying
Amouyal Philippe — 4 qualifying
SOBECKI CHRISTOPHER J — 56 qualifying
Artal Group S.A. — 82 qualifying
Ulys, L.L.C. — 14 qualifying
Invus Advisors, L.L.C. — 44 qualifying
McDermott Wendy — 2 qualifying
Wittouck Amaury — 29 qualifying
WADE JEFFREY L — 4 qualifying
BARKER SAM L — 34 qualifying

Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.